GeoVax Labs share price logo

GeoVax Labs

NASDAQ: GOVX

$0.17

-0.02

(-9.31%)

as on

GeoVax Labs Stock Performance

as on November 2, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.17
    $0.18
    downward going graph

    -0.83%

    Downside

    6.76%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.17
    $14.35
    downward going graph

    2.08%

    Downside

    8409.79%

    Upside

    downward going graph

GeoVax Labs share price movements today

Previous Close
$0.19
Open
$0.18
Volume
1.6M
Market Cap
$1.7M
Day's Low - High
$0.17 - $0.18
52 Week Low - High
$0.17 - $14.35

GeoVax Labs Historical Returns

1 Month Return
-47.33 %
3 Month Return
-75.25 %
1 Year Return
-98.81 %
3 Year Return
-99.92 %
5 Year Return
-99.99 %

GeoVax Labs Stock Fundamentals & Key Indicators

Check GeoVax Labs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.7M

EPS (TTM)

-13.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.01

Industry PE ratio

-3.13

PEG Ratio

-0.00

EBITDA

-20.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-743.66%

GeoVax Labs vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of GeoVax Labs with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
GeoVax Labs image
GeoVax Labs
Buy$1.7M-99.99%-0.010.00%0.00%
Moderna image
Moderna
Neutral$88.5B-36.40%-27.78-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B208.09%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B45.26%19.7685.77%0.40%

Stock Returns calculator for GeoVax Labs Stock including INR - Dollar returns

The GeoVax Labs stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

GeoVax Labs investment value today

Current value as on today

₹1,276

Returns

-₹98,724

(-98.72%)

Returns from GeoVax Labs Stock

-₹98,808 (-98.81%)

Dollar Impact

₹84 (+0.08%)

Analyst Recommendation on GeoVax Labs Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for GeoVax Labs. Average target price of $10

GeoVax Labs Share Price Target

Get share price movements and forecasts by analysts on GeoVax Labs.

What analysts predicted

98.31%UPSIDE

Target Price

$10

Current Price

$0.1686

Analyzed by

9 Analysts

Target

$10.00

GeoVax Labs target price $10, a slight upside of 98.31% compared to current price of $0.1686. According to 9 analysts rating.

Indian Investors' Interest in GeoVax Labs Stock

Search interest for GeoVax Labs Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:8% versus previous 30 day period

GeoVax Labs Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
0
2
0
1
0
-
-
-
-
Gross Profit
0
-3
-4
0
-3
-3
-5
0
-3
0
Operating Income
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
EBITDA
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Interest Expense
-
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Net Profit Margin
0.00%
100.00%
100.00%
97.50%
-227.12%
-454.86%
0.00%
0.00%
0.00%
0.00%

GeoVax Labs Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
0
1
1
0
0
-
3
2
Gross Profit
0
0
1
1
-15
-9
-20
3
-15
Operating Income
-2
-2
-2
-2
-18
-14
-26
-25
-21
EBITDA
-2
-2
-2
-2
-18
-13
-25
-24
-21
Interest Expense
-
0
0
0
0
-
-
0
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-2
-2
-18
-14
-25
-24
-21
Income Tax Expense
-
0
-
-
-
-
-
-
-
Net Income
-2
-2
-2
-2
-18
-14
-25
-24
-21
Net Profit Margin
-87.61%
-95.08%
100.00%
100.00%
100.00%
-11090.88%
0.00%
97.59%
-628.02%

GeoVax Labs Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-5
-5
-5
-8
-5
-5
-6
-4
-5
-4
Operating Cash Flow
-5
-1
-9
-7
-5
-4
-6
-4
-3
-3
Investing Cash Flow
-
-
0
-
0
0
-
-
-
-
Financing Cash Flow
-
2
16
4
7
0
8
3
1
5
Change in Cash
-5
0
7
-3
1
-4
1
-1
-1
1

GeoVax Labs Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-2
-2
-2
-2
-18
-14
-25
-24
-21
Operating Cash Flow
-1
-1
-1
-2
-11
-19
-25
-24
-21
Investing Cash Flow
0
-
0
0
0
0
0
0
0
Financing Cash Flow
1
1
1
12
12
35
4
23
19
Change in Cash
0
0
0
9
1
16
-21
0
-2

Global Institutional Holdings in GeoVax Labs

Check out the Institutions with significant holdings in GeoVax Labs.

Funds
Holdings
Robert T. McNally
0.53%
David Dodd
0.36%
Randal Chase
0.36%
John N. Spencer
0.21%
Fidelity Concord Street Trust
0.21%
See all

GeoVax Labs News & Key Events

  • img

    Today's Timeline - 27 October

    Tue, 07:00 PM

    -

    GeoVax secures a $1 million loan facility and reshapes its board with new lender-nominated directors.

    Tue, 10:57 PM

    -

    Stockholders approve warrants issuance and a reverse stock split to support Nasdaq compliance and financing flexibility.

Insights on GeoVax Labs

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 815.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 311.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, GOVX stock has moved down by -13.3%

About GeoVax Labs

GeoVax Labs, Inc. is a biotechnology company in the clinical development phase, focused on creating innovative human vaccines and immunotherapies. The firm targets both infectious diseases and various cancer types, utilizing its proprietary modified vaccinia ankara (MVA) virus-like particle (VLP) vaccine platform. Its product pipeline includes several prophylactic vaccines aimed at preventing illnesses such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and a range of hemorrhagic fevers like Ebola, Sudan, Marburg, and Lassa. Additionally, GeoVax is developing therapeutic vaccines designed to treat existing conditions, specifically HIV, chronic Hepatitis B infections, and solid tumor cancers. To support its research and development efforts, GeoVax Labs, Inc. has forged partnerships with notable organizations. These collaborators include the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health), the Centers for Disease Control and Prevention, the U.S. Department of Defense, Emory University, the University of Pittsburgh, and the Burnet Institute. Founded in 1988, GeoVax Labs, Inc. is headquartered in Smyrna, Georgia.
OrganisationGeoVax Labs
Headquarters1900 Lake Park Drive, Smyrna, GA, 30080, US
IndustryBiotechnology
CEODavid Alan Dodd

Key Management of GeoVax Labs

Name

Title

Dr. Kelly T. McKee Jr., M.D., M.P.H.

Chief Medical Officer

Mr. Mark W. Reynolds CPA

CFO & Corporate Secretary

Mr. Thomas O'Brien

Vice President of Quality Systems & Compliance

Mr. Jeffrey Welch

Head of Process Development & Manufacturing Operations

Dr. John W. Sharkey Ph.D.

Vice President of Business Development

Mr. David Alan Dodd

Chairman, President & CEO

Dr. Mark J. Newman Ph.D.

Chief Scientific Officer

FAQs

What is GeoVax Labs share price today?

GeoVax Labs share price today is $0.17 as on at the close of the market. GeoVax Labs share today touched a day high of $0.18 and a low of $0.17.

What is the 52 week high and 52 week low for GeoVax Labs share?

GeoVax Labs share touched a 52 week high of $14.35 on and a 52 week low of $0.17 on . GeoVax Labs stock price today i.e. is closed at $0.17,which is 98.82% down from its 52 week high and 2.12% up from its 52 week low.

What is GeoVax Labs's market capitalisation today?

GeoVax Labs market capitalisation is $0.00T as on .

How to invest in GeoVax Labs Stock (GOVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for GeoVax Labs on INDmoney app. Click on Buy button.

What is the minimum amount required to buy GeoVax Labs Stock (GOVX) from India?

Indian investors can start investing in GeoVax Labs (GOVX) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in GeoVax Labs stock (as per the Rupee-Dollar exchange rate as on ). Based on GeoVax Labs share’s latest price of $0.17 as on November 2, 2026 at 8:46 am IST, you will get 59.3120 shares of GeoVax Labs. Learn more about fractional shares .

What are the returns that GeoVax Labs has given to Indian investors in the last 5 years?

GeoVax Labs stock has given -99.99% share price returns and 27.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?